FGAM
DNA icon

Financial Gravity Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Financial Gravity Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$1.46K – 808
2025
Q3 		$1.46K Buy
+100
New +$1.2K ﹤0.01% 785
2024
Q2 		– Sell
-2
Closed -$76 – 1503
2024
Q1 		$76 Buy
2
+1
+100% +$52 ﹤0.01% 998
2023
Q4 		$39 Buy
+1
New +$61 ﹤0.01% 1165

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Gravity Asset Management's DNA Position: Q4 2025 in Review

Financial Gravity Asset Management sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 100 shares — an estimated $1.46K sold.

Financial Gravity Asset Management first reported a position in DNA in Q4 2023 and held it in 3 quarters. The position peaked at $1.46K in Q3 2025. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Financial Gravity Asset Management reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Financial Gravity Asset Management sold 100 Ginkgo Bioworks shares in Q4 2025, an estimated $1.46K.
  • Financial Gravity Asset Management first reported a position in Ginkgo Bioworks in Q4 2023 and held it in 3 quarters.
  • Financial Gravity Asset Management's Ginkgo Bioworks position peaked at $1.46K in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Financial Gravity Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.